NCT01452009

Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%

Three Month Safety and Efficacy Study of TRAVATAN® vs Travoprost Ophthalmic Solution, 0.004%

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A multi-center, observer-masked, randomized, parallel group efficacy and safety study of TRAVATAN® versus a new formulation of Travoprost Ophthalmic Solution, 0.004%

Conditions

• Open Angle Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	Travoprost Ophthalmic Solution, 0.004% (New Formulation)	Travoprost Ophthalmic Solution, 0.004% given one drop once daily
DRUG	TRAVATAN®	TRAVATAN® administered one drop once daily

Timeline

• Start date: 2011-11-01
• Primary completion: 2011-12-01
• Completion: 2011-12-01
• First posted: 2011-10-14
• Last updated: 2012-02-10